Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

S*BIO discloses novel mTOR inhibitors

July 22, 2011

Merck KGaA presents novel PDK1 inhibitors with potential to treat cancer

July 22, 2011

Single-vial Taxotere formulation launched in Japan

July 21, 2011

First patient enrolled in NCI's pediatric phase I trial of Marqibo

July 21, 2011

Taiho and Nordic Group to collaborate on Teysuno

July 21, 2011

Chinese university presents new antitumor noscapine derivatives

July 21, 2011

New irreversible epidermal growth factor receptor inhibitor shows preclinical antitumor activity

July 21, 2011

Halaven launched in Japan for inoperable/recurrent breast cancer

July 19, 2011

Talon Therapeutics submits NDA for Marqibo to FDA

July 19, 2011

Cyclacel and Daiichi Sankyo amend sapacitabine licensing agreement

July 19, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...